Search research articles
Contact Us
Filters
Showing results (51-60 of 55) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 55 results.
Clinical Orthopaedics and Related Research
|
October 4, 2019
Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial
Dimosthenis Andreou, Andreas Ranft, Georg Gosheger, et al.
Nature Communications
|
December 4, 2015
Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
Michal Kovac, Claudia Blattmann, Sebastian Ribi, et al.
Cancers
|
December 28, 2019
Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models
Maria Anna Smolle, Michiel van de Sande, Dario Callegaro, et al.
Tumori
|
December 9, 2017
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma
Stefano Ferrari, Stefan S Bielack, Sigbjørn Smeland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2015
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
Stefan S Bielack, Sigbjørn Smeland, Jeremy S Whelan, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 55) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 55 results.
Clinical Orthopaedics and Related Research
|
October 4, 2019
Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial
Dimosthenis Andreou, Andreas Ranft, Georg Gosheger, et al.
Nature Communications
|
December 4, 2015
Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
Michal Kovac, Claudia Blattmann, Sebastian Ribi, et al.
Cancers
|
December 28, 2019
Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models
Maria Anna Smolle, Michiel van de Sande, Dario Callegaro, et al.
Tumori
|
December 9, 2017
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma
Stefano Ferrari, Stefan S Bielack, Sigbjørn Smeland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2015
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
Stefan S Bielack, Sigbjørn Smeland, Jeremy S Whelan, et al.
Page
of 6